Therapeutic outcomes in patients undergoing surgery after diagnosis of Cushing's disease: A single-center study.
暂无分享,去创建一个
S. Yamada | Y. Takeuchi | N. Inoshita | H. Nishioka | Hisanori Suzuki | A. Takeshita | Junko Ito | Noriaki Fukuhara | M. Yamaguchi-Okada | M. Yamaguchi‐Okada
[1] N. Sakai,et al. X-ray Angiography Perfusion Analysis for the Balloon Occlusion Test of the Internal Carotid Artery. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[2] P. Chanson,et al. Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence. , 2015, European journal of endocrinology.
[3] T. C. Rodrigues,et al. Evaluation of Cushing's disease remission after transsphenoidal surgery based on early serum cortisol dynamics , 2014, Clinical endocrinology.
[4] M. Buchfelder,et al. Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing's disease: care reality in the Munich Metropolitan Region. , 2014, European journal of endocrinology.
[5] A. Fassina,et al. Predicting late recurrence in surgically treated patients with Cushing's disease , 2013, Clinical endocrinology.
[6] S. Chew,et al. Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study. , 2013, European journal of endocrinology.
[7] R. Weil,et al. Outcome of surgical treatment of 200 children with Cushing's disease. , 2013, The Journal of clinical endocrinology and metabolism.
[8] S. Gultekin,et al. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing’s disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience , 2013, Pituitary.
[9] A. Grossman,et al. The Therapy of Cushing’s Disease in Adults and Children: An Update , 2012, Hormone and Metabolic Research.
[10] R. Feelders,et al. The burden of Cushing's disease: clinical and health-related quality of life aspects. , 2012, European journal of endocrinology.
[11] S. Sheth,et al. Transsphenoidal surgery for cushing disease after nondiagnostic inferior petrosal sinus sampling. , 2012, Neurosurgery.
[12] T. Sano,et al. Correlation Between Histological Subtypes and MRI Findings in Clinically Nonfunctioning Pituitary Adenomas , 2012, Endocrine Pathology.
[13] F. Beuschlein,et al. Contemporary microsurgical concept for the treatment of Cushing’s disease: endocrine outcome in 83 consecutive patients , 2012, Clinical endocrinology.
[14] S. Yamada,et al. Surgical management and outcomes in patients with Cushing disease with negative pituitary magnetic resonance imaging. , 2012, World neurosurgery.
[15] S. Yamada,et al. Simultaneous combined supra-infrasellar approach for giant/large multilobulated pituitary adenomas. , 2012, World neurosurgery.
[16] J. Liu. Transsphenoidal Surgery for Cushing Disease: Experience With 136 Patients , 2012 .
[17] S. Paek,et al. Recurrence of Cushing's disease after primary transsphenoidal surgery in a university hospital in Korea. , 2012, Endocrine journal.
[18] H. Raff,et al. Prolactin as a marker of successful catheterization during IPSS in patients with ACTH-dependent Cushing's syndrome. , 2011, The Journal of clinical endocrinology and metabolism.
[19] E. Oldfield,et al. The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery. , 2011, The Journal of clinical endocrinology and metabolism.
[20] P. Jones,et al. Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. , 2011, The Journal of clinical endocrinology and metabolism.
[21] S. Yamada,et al. Repeat Transsphenoidal Surgery for the Treatment of Remaining or Recurring Pituitary Tumors in Acromegaly , 2010, Neurosurgery.
[22] S. Lamberts,et al. Biochemical Predictors of Outcome of Pituitary Surgery for Cushing’s Disease , 2009, Neuroendocrinology.
[23] A. Takeshita,et al. High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease. , 2009, European journal of endocrinology.
[24] S. Yamada,et al. Successful treatment of Cushing’s disease caused by ectopic intracavernous microadenoma , 2011, Pituitary.
[25] M. Aghi. Management of recurrent and refractory Cushing disease , 2008, Nature Clinical Practice Endocrinology &Metabolism.
[26] E. Laws,et al. OUTCOMES AFTER REPEAT TRANSSPHENOIDAL SURGERY FOR RECURRENT CUSHING'S DISEASE , 2008, Neurosurgery.
[27] W. Ludlam. Treatment of Adrenocorticotropin-Dependent Cushing's Syndrome: A Consensus Statement , 2008 .
[28] M. Czepielewski,et al. Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease. , 2007, Arquivos brasileiros de endocrinologia e metabologia.
[29] M. Fleseriu,et al. Treatment options for Cushing disease after unsuccessful transsphenoidal surgery. , 2007, Neurosurgical focus.
[30] E. Laws,et al. The role of inferior petrosal sinus sampling in the diagnostic localization of Cushing's disease. , 2007, Neurosurgical focus.
[31] D. Kelly. Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome. , 2007, Neurosurgical focus.
[32] M. Boakye,et al. National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002. , 2007, Neurosurgical focus.
[33] A. Pontecorvi,et al. Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease. , 2007, European journal of endocrinology.
[34] S. Yamada,et al. FSH-producing macroadenoma associated in a patient with Cushing's disease. , 2006, Neuro endocrinology letters.
[35] Charles B. Wilson,et al. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. , 2004, The Journal of clinical endocrinology and metabolism.
[36] R. DeLellis. Pathology and genetics of tumours of endocrine organs , 2004 .
[37] B. Scheithauer,et al. Crooke's Cell Adenoma of the Pituitary: An Aggressive Variant of Corticotroph Adenoma , 2003, The American journal of surgical pathology.
[38] D. Lüdecke,et al. Cushing's disease: a surgical view. , 2001, Journal of neuro-oncology.
[39] G. Tindall,et al. Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas. , 1998, The Journal of clinical endocrinology and metabolism.
[40] A. Ragin,et al. Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. , 1997, Neurosurgery.
[41] M. Buchfelder,et al. Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. , 1995, The Journal of clinical endocrinology and metabolism.